IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced results from a recent survey of eye care professionals and the availability of an open letter website in response to requests from physician customers for a platform to voice their concerns regarding the unsolicited proposal from Valeant Pharmaceuticals International, Inc. (“Valeant”) to acquire Allergan.
In a national survey conducted by M3 Global Research and sponsored by Allergan1, 604 ophthalmologists (n=300) and optometrists (n=304) shared their perspectives on the industry and what they value most in eye care companies.
Help employers find you! Check out all the jobs and post your resume.
In a national survey conducted by M3 Global Research and sponsored by Allergan1, 604 ophthalmologists (n=300) and optometrists (n=304) shared their perspectives on the industry and what they value most in eye care companies.
Help employers find you! Check out all the jobs and post your resume.
